433
Views
71
CrossRef citations to date
0
Altmetric
Review

The Role of Lactobacillus Probiotics in the Treatment or Prevention of Urogenital Infections – A Systematic Review

Pages 243-252 | Published online: 18 Jul 2013

REFERENCES

  • Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Candida vaginitis: self-reported incidence and associated costs. Sex Transm Dis. 2000; 27: 230–235.
  • McGregor JA, French JI. Bacterial vaginosis in pregnancy. Obstet Gynecol Surv. 2000; 55: S1–19.
  • Muller E, Berger K, Dennemark N, Oleen-Burkey M. Cost of bacterial vaginosis in pregnancy. Decision analysis and cost evaluation of a clinical study in Germany. J Reprod Med. 1999; 44: 807–814.
  • Weaver CH, Mengel MB. Bacterial vaginosis. J Fam Pract. 1988; 27: 207–215.
  • Andersch B, Lindell D, Dahlen I, Brandberg A. Bacterial vaginosis and the effect of intermittent prophylactic treatment with an acid lactate gel. Gynecol Obstet Invest. 1990; 30: 114–119.
  • Levett PN. Bacterial vaginosis. West Indian Med J. 1989; 38: 126–132.
  • Reed BD, Eyler A. Vaginal infections: diagnosis and man-agement. Am Fam Physician. 1993; 47: 1805–1818.
  • Sobel JD. Epidemiology and pathogenesis of recurrent vul-vovaginal candidiasis. Am J Obstet Gynecol. 1985; 152: 924–935.
  • Sobel JD. Bacterial vaginosis. Br J Clin Pract Suppl. 1990; 71: 65–69.
  • Reid G, Bruce AW. Urogenital infections in women: can probiotics help? Postgrad Med J. 2003; 79: 428–432.
  • Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr. 2001; 73: 437S-443S.
  • Reid G, Bruce AW. Selection of lactobacillus strains for urogenital probiotic applications. J Infect Dis. 2001;183 Suppl 1: S77–80.
  • Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. London, On-tario, Canada; April 30 and May 1, 2002.
  • McGroarty JA. Probiotic use of lactobacilli in the human female urogenital tract. FEMS Immunol Med Microbiol. 1993; 6: 251–264.
  • De Mitchell I, Kenworthy R. Investigations on a metabolite from Lactobacillus bulgaricus which neutralizes the effect of en-terotoxin from Escherichia coil pathogenic for pigs. J Appl Bac-teriol. 1976; 41: 163–174.
  • Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis. 2006; 6: 374–382.
  • Dendukuri N, Costa V, McGregor M, Brophy JM. Probi-otic therapy for the prevention and treatment of Clostridium dif-ficile-associated diarrhea: a systematic review. CMAJ. 2005; 173: 167–170.
  • McFarland LV. Meta-analysis of probiotics for the preven-tion of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006; 101: 812–822.
  • Brigidi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D. Effects of probiotic administration upon the composition and en-zymatic activity of human fecal microbiota in patients with irrita-ble bowel syndrome or functional diarrhea. Res Microbiol. 2001; 152: 735–741.
  • Gionchetti P, Rizzello F, Venturi A, et al. Oral bacterio-therapy as maintenance treatment in patients with chronic pou-chitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000; 119: 305–309.
  • Lee SJ, Shim YH, Cho SJ, Lee JW. Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatr Nephrol. 2007; 22: 1315–1320.
  • Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacte-rial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate. 2002; 82: 103–108.
  • Raz R, Colodner R, Rohana Y, et al. Effectiveness of es-triol-containing vaginal pessaries and nitrofurantoin macrocnistal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. Clin Infect Dis. 2003; 36: 1362–1368.
  • Raz R, Stamm WE. A controlled trial of intravaginal es-triol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993; 329: 753–756.
  • Thomas KK, Sanchez S, Garcia PJ, Holmes KK. Why do different criteria for ‘cure’ yield different conclusions in compar-ing two treatments for bacterial vaginosis? Sex Transm Dis. 2005; 32: 526–530.
  • Decena DC, Co JT, Manalastas RM, Jr., et al. Metron-idazole with Lactacyd vaginal gel in bacterial vaginosis. J Obstet Gynaecol Res. 2006; 32: 243–251.
  • Ness RB, Hillier SL, Richter HE, et al. Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol. 2002; 100: 765.
  • Cotch MF, Hillier SL, Gibbs RS, Eschenbach DA. Epi-demiology and outcomes associated with moderate to heavy Can-dida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1998; 178: 374–380.
  • Williams A. CVV in women with HIV. Adv Nurse Pract. 2005; 13: 15.
  • Engberts MK, Boon ME, van Haaften M, Heintz AP. Symptomatic candidiasis: Using self sampled vaginal smears to establish the presence of Candida, lactobacilli, and Gardnerella vaginalis. Diagn Cytopathol. 2007; 35: 635–639.
  • Hawes SE, Hillier SL, Benedetti J, et al. Hydrogen per-oxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis. 1996; 174: 1058–1063.
  • Bruce AW, Reid G, McGroarty JA, Taylor M, Preston C. Preliminary study on the prevention of recurrent urinary tract in-fection in adult women using intravaginal lactobacilli. Int Urogy-necol J. 1992; 3: 22–25.
  • Uehara S, Monden K, Nomoto K, Seno Y, Kariyama R, Kumon H. A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent uri-nary tract infection. Int J Antimicrob Agents. 2006;28 Suppl 1: S30–34.
  • Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol. 2001; 30: 49–52.
  • Hilton E, Rindos P, Isenberg HD. Lactobacillus GG vagi-nal suppositories and vaginitis. J Clin Microbiol. 1995; 33: 1433.
  • Hilton E, Isenberg HD, Alperstein P, France K, Borenstein MT. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med. 1992; 116: 353–357.
  • Friedlander A, Druker MM, Schachter A. Lactobacillus acidophillus and vitamin B complex in the treatment of vaginal infection. Panminerva Med. 1986; 28: 51–53.
  • Drago L, De Vecchi E, Nicola L, Zucchetti E, Gismondo MR, Vicariotto F. Activity of a Lactobacillus acidophilus-based douche for the treatment of bacterial vaginosis. J Altern Com-plement Med. 2007; 13: 435–438.
  • Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol. 2001; 32: 37–41.
  • Pirotta M, Gunn J, Chondros P, et al. Effect of lactobacil-lus in preventing post-antibiotic vulvovaginal candidiasis: a ran-domised controlled trial. Br Med J. 2004; 329: 548.
  • Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecology Ther. 1995; 23: 32–45.
  • Reid G, Bruce AW, Taylor M. Influence of three-day an-timicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther. 1992; 14: 11–16.
  • Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. Bmj. 2001; 322: 1571.
  • Shalev E, Battino S, Weiner E, Colodner R, Keness Y. In-gestion of yogurt containing Lactobacillus acidophilus com-pared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med. 1996; 5: 593–596.
  • Cadieux P, Burton J, Gardiner G, et al. Lactobacillus strains and vaginal ecology. Jama. 2002; 287: 1940–1941.
  • Colodner R, Edelstein H, Chazan B, Raz R. Vaginal colo-nization by orally administered Lactobacillus rhamnosus GG. Isr Med Assoc J. 2003; 5: 767–769.
  • Reid G, Charbonneau D, Erb J, et al. Oral use of Lacto-bacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003; 35: 131–134.
  • Ozkinay E, Terek MC, Yayci M, Kaiser R, Grob P, Tuncay G. The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treat-ment of vaginal infections. BJOG. 2005; 112: 234–240.
  • Williams AB, Yu C, Tashima K, Burgess J, Danvers K. Evaluation of two self-care treatments for prevention of vaginal candidiasis in women with HIV. J Assoc Nurses AIDS Care. 2001; 12: 51–57.
  • Neri A, Sabah G, Samra Z. Bacterial vaginosis in preg-nancy treated with yoghurt. Acta Obstet Gynecol Scand. 1993; 72: 17–19.
  • Spiegel CA. Bacterial vaginosis. Clin Microbiol Rev. 1991; 4: 485–502.
  • Nugent RP, Krohn MA, Hillier SL. Reliability of diagnos-ing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991; 29: 297–301.
  • Parent D, Bossens M, Bayot D, et al. Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clini-cal trial. Arzneimittelforschung. 1996; 46: 68–73.
  • Hallen A, Jarstrand C, Pahlson C. Treatment of bacterial vaginosis with lactobacilli. Sex Transm Dis. 1992; 19: 146–148.
  • Eriksson K, Carlsson B, Forsum U, Larsson PG. A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules. Acta Derm Venereol. 2005; 85: 42–46.
  • Myziuk L, Romanowski B, Johnson SC. BV Blue test for diagnosis of bacterial vaginosis. J Clin Microbiol. 2003; 41: 1925–1928.
  • Anukam K, Osazuwa E, Ahonkhai I, et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect 2006; 8: 1450–1454.
  • Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, Reid G. Clinical study comparing probiotic Lacto-bacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect 2006; 8: 2772–2776.
  • Hillier SL, Wiesenfeld HC, Murray P, Busse B, Krohn MA, Marrazzo JM. A trial of Intravaginal Lactobacillus crispatus as an adjunct to metronidazole therapy for treatment of bacterial vaginosis. Program and abstracts of the annual meeting and research symposium of the Infectious Disease Society of Obstet-rics and Gynecology. Ottawa, Canada 2002.
  • Reid G, Millsap K, Bruce AW. Implantation of Lacto-bacillus casei var rhamnosus into vagina. Lancet. 1994; 344: 1229.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.